These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8874257)

  • 1. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia.
    Milani RV; Mehra MR; Endres S; Eigler A; Cooper ES; Lavie CJ; Ventura HO
    Chest; 1996 Oct; 110(4):992-5. PubMed ID: 8874257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM
    Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure.
    Ferrari R; Bachetti T; Confortini R; Opasich C; Febo O; Corti A; Cassani G; Visioli O
    Circulation; 1995 Sep; 92(6):1479-86. PubMed ID: 7664430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
    Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
    J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.
    Genth-Zotz S; von Haehling S; Bolger AP; Kalra PR; Wensel R; Coats AJ; Anker SD
    Am J Cardiol; 2002 Dec; 90(11):1226-30. PubMed ID: 12450603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation.
    Katz SD; Rao R; Berman JW; Schwarz M; Demopoulos L; Bijou R; LeJemtel TH
    Circulation; 1994 Jul; 90(1):12-6. PubMed ID: 8025986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure.
    Kubota T; Miyagishima M; Alvarez RJ; Kormos R; Rosenblum WD; Demetris AJ; Semigran MJ; Dec GW; Holubkov R; McTiernan CF; Mann DL; Feldman AM; McNamara DM
    J Heart Lung Transplant; 2000 Sep; 19(9):819-24. PubMed ID: 11008069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure.
    Zhao SP; Xu TD
    Int J Cardiol; 1999 Dec; 71(3):257-61. PubMed ID: 10636532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure.
    Stumpf C; Lehner C; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2003 Jul; 105(1):45-50. PubMed ID: 12639217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial.
    Kubota T; McNamara DM; Wang JJ; Trost M; McTiernan CF; Mann DL; Feldman AM
    Circulation; 1998 Jun; 97(25):2499-501. PubMed ID: 9657468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).
    Torre-Amione G; Kapadia S; Benedict C; Oral H; Young JB; Mann DL
    J Am Coll Cardiol; 1996 Apr; 27(5):1201-6. PubMed ID: 8609343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation.
    Mohler ER; Sorensen LC; Ghali JK; Schocken DD; Willis PW; Bowers JA; Cropp AB; Pressler ML
    J Am Coll Cardiol; 1997 Jul; 30(1):35-41. PubMed ID: 9207618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
    White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
    Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level.
    Saitoh M; Osanai T; Kamada T; Matsunaga T; Ishizaka H; Hanada H; Okumura K
    Heart Vessels; 2003 Sep; 18(4):177-82. PubMed ID: 14520484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carni Q-gel (ubiquinol and carnitine) on cytokines in patients with heart failure in the Tishcon study.
    Kumar A; Singh RB; Saxena M; Niaz MA; Josh SR; Chattopadhyay P; Mechirova V; Pella D; Fedacko J
    Acta Cardiol; 2007 Aug; 62(4):349-54. PubMed ID: 17824295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.